These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17296575)

  • 1. The association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13.
    Davies JA; Bowen DJ
    Haematologica; 2007 Feb; 92(2):240-3. PubMed ID: 17296575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro.
    Keeney S; Grundy P; Collins PW; Bowen DJ
    Haemophilia; 2007 Jul; 13(4):405-8. PubMed ID: 17610557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
    Bowen DJ; Collins PW
    Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Acta Haematol; 2009; 121(2-3):98-101. PubMed ID: 19506354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
    Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
    Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
    Hassenpflug WA; Budde U; Obser T; Angerhaus D; Drewke E; Schneppenheim S; Schneppenheim R
    Blood; 2006 Mar; 107(6):2339-45. PubMed ID: 16322474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
    Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
    Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function.
    Luken BM; Winn LY; Emsley J; Lane DA; Crawley JT
    Blood; 2010 Jun; 115(23):4910-3. PubMed ID: 20354169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased susceptibility of recombinant type 2A von Willebrand factor mutant A1500E to proteolysis by ADAMTS13].
    Zhang JY; Su J; Ma ZN; Dong NZ; Wang YC; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):169-72. PubMed ID: 22781599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
    Schneppenheim R; Michiels JJ; Obser T; Oyen F; Pieconka A; Schneppenheim S; Will K; Zieger B; Budde U
    Blood; 2010 Jun; 115(23):4894-901. PubMed ID: 20351307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into von Willebrand factor proteolysis: clinical implications.
    Bowen DJ; Collins PW
    Br J Haematol; 2006 Jun; 133(5):457-67. PubMed ID: 16681634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype.
    Bowen DJ; Collins PW; Lester W; Cumming AM; Keeney S; Grundy P; Enayat SM; Bolton-Maggs PH; Keeling DM; Khair K; Tait RC; Wilde JT; Pasi KJ; Hill FG;
    Br J Haematol; 2005 Mar; 128(6):830-6. PubMed ID: 15755288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of von Willebrand factor Y/C1584 on in vivo protein level and function and interaction with ABO blood group.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Blood; 2007 Apr; 109(7):2840-6. PubMed ID: 17119126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 von Willebrand disease: a possible novel mechanism.
    Bowen D
    Blood Coagul Fibrinolysis; 2004 May; 15 Suppl 1():S21-3. PubMed ID: 15166929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
    Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
    Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
    Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C
    PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycan stabilization of the VWF A2 domain.
    Lynch CJ; Lane DA
    Blood; 2016 Mar; 127(13):1711-8. PubMed ID: 26773038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis.
    Baldauf C; Schneppenheim R; Stacklies W; Obser T; Pieconka A; Schneppenheim S; Budde U; Zhou J; Gräter F
    J Thromb Haemost; 2009 Dec; 7(12):2096-105. PubMed ID: 19817991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.